GAITHERSBURG, Md., Jan. 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the 44th Annual J.P. Morgan Healthcare Conference.
Conference Details: | |
Presentation | |
Date: | Wednesday, January 14, 2026 |
Time: | 4:30 p.m. Pacific Time |
Location: | San Francisco, CA |
A webcast of the presentation will be available on the Events & Presentations page of the Company's website at ir.novavax.com. A replay of the webcast will be available for 30 days.
About NovavaxNovavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M® adjuvant. The Company's growth strategy seeks to optimize its existing partnerships and expand access to its proven technology platform via research and development innovation, organic portfolio expansion in infectious disease and beyond, and forging new partnerships and collaborations with other companies. Please visit novavax.com and LinkedIn for more information.
Contacts:
InvestorsLuis Sanay, CFA 240-268-2022[email protected]
MediaYvonne Sprow240-720-7804[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-the-44th-annual-jp-morgan-healthcare-conference-302654454.html
SOURCE Novavax, Inc.